Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Opexa Therapeutics Inc (NASDAQ:OPXA)

0.40
Delayed Data
As of Aug 04
 +0.0166 / +4.33%
Today’s Change
0.33
Today|||52-Week Range
1.59
-44.44%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues307.7K307.7K307.7K377.5K
 
 
 
 
 
Depreciation And Amortization98.7K97.4K96.2K97.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses4.4M4.1M3.6M3.6M
 
 
 
 
 
Research And Development3.4M3.2M2.7M2.6M
 
 
 
 
 
Total Operating Expenses4.5M4.2M3.7M3.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.2M-3.9M-3.4M-3.4M
 
 
 
 
 
Interest Expense On Debt0.00958.001.0K0.00
 
 
 
Other Expenses0.000.002.1K10.3K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.2M-3.9M-3.4M-3.4M
 
 
 
 
 
Net Income-4.2M-3.9M-3.4M-3.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS27.7M27.8M28.2M28.2M
 
 
 
 
 
Shares To Calculate EPS Diluted27.7M27.8M28.2M28.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.15-$0.14-$0.12-$0.12
 
 
 
 
 
EPS Diluted-$0.15-$0.14-$0.12-$0.12